Birzeit Pharmaceutical Co

NEW
XPAE:BPC (Palestine)  
$ 3.67 -0.010 (-0.27%) Jul 14
11.33
P/B:
1.25
Market Cap:
$ 142.27M
Enterprise V:
$ 139.50M
Volume:
300.00
Avg Vol (2M):
11.58K
Trade In:
Volume:
300.00
Avg Vol (2M):
11.58K

Birzeit Pharmaceutical Co’s share price is $3.67. Its GF Value is $4.59. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Birzeit Pharmaceutical Co stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: $3.67 GF Value Price/GF Value
Current $4.59 0.80
Next FY1 End $4.61 0.80
Next 12 Month $4.63 0.79
Next FY2 End $4.64 0.79
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Birzeit Pharmaceutical Co's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Birzeit Pharmaceutical Co's stock price and Book Value per share, with a coefficient of 76%. Birzeit Pharmaceutical Co’s stock price shows no significant correlation with Operating Cash Flow per share. Birzeit Pharmaceutical Co’s stock price shows no significant correlation with Revenue per share. Birzeit Pharmaceutical Co’s stock price shows no significant correlation with Earnings without NRI per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies